Overview
2026 I-SCORE: Investigators' and Site Coordinators' Opportunity for Research Excellence Annual Meeting
Thursday, March 26, 2026, from 9:00 am – 5:00 pm ET
Friday, March 27, 2026, from 9:00 am – 12:30 pm ET
The NCI Division of Cancer Prevention (DCP) develops, supports, and oversees clinical cancer prevention trials and promotes participation by all populations. The Early Phase Cancer Prevention Clinical Trials Program is designed to evaluate the safety and efficacy of promising new preventive agents, the utility of novel biomarkers, and the value of innovative technologies to identify premalignant lesions. The Cancer Prevention Clinical Trials Network (CP-CTNet) was created to facilitate the efficient implementation of these studies by teams of multidisciplinary investigators supported by NCI DCP. The purpose of the I-SCORE meeting is to stimulate information sharing and collaborations between DCP staff and CP-CTNet members including investigators, program staff and coordinators; and to develop strategies to enhance the cancer prevention research program both scientifically and operationally.